Showing results (41-50 of 1,512) with videos related to

Sort By:
Pageof 152
Zeitschrift Fur Kardiologie|December 1, 1996
[Initial clinical experiences with low energy internal cardioversion of chronic atrial fibrillation after unsuccessful external cardioversion]A Heisel, J Jung, E Rippl, et al.
The American Journal of Cardiology|December 1, 1995
Comparison of mortality from acute myocardial infarction in patients receiving anistreplase with those not receiving thrombolysisC Ozbek, A Heisel, M Krause, et al.
International Journal of Cardiology|May 23, 1997
Incidence and clinical significance of short-term recurrent ventricular tachyarrhythmias in patients with implantable cardioverter-defibrillatorR Fries, A Heisel, H Huwer, et al.
International Angiology : a Journal of the International Union of Angiology|March 1, 1994
Hypervolemic hemodilution with or without venesection in peripheral arterial occlusive disease stage IIH Kiesewetter, F Jung, A Birk, et al.
Acta Medica Austriaca|January 1, 1991
[Hemorheologic and circulatory effects of hemodilution with medium molecular weight hydroxyethyl starch in two concentrations (HAES 200/0.62 10% and 6%)]F Jung, P Waldhausen, S Spitzer, et al.
Biomedizinische Technik. Biomedical Engineering|April 29, 1998
Electron-microscopic examination of silicon-carbide-coated endovascular stentsF Jung, R Bach, R P Franke
Zeitschrift Fur Kardiologie|November 1, 1990
[Third replacement of the tricuspid valve in combined aortic-tricuspid defect]S Spitzer, H Schwerdt, W Vogel, et al.
Microvascular Research|November 18, 2000
Influence of a new monomeric nonionic radiographic contrast medium (iobitridol-350 versus NaCl) on cutaneous microcirculation: single-center, prospective, randomized, double-blind phase IV study in parallel group designR Bach, U Gerk, C Mrowietz, et al.
Biomedizinische Technik. Biomedical Engineering|October 1, 1990
[The clinical rheological laboratory]H Kiesewetter, F Jung, S Spitzer, et al.
Acta Medica Austriaca|January 1, 1991
[Hyper- or isovolemic hemodilution in patients with stage II peripheral arterial occlusive disease]H Kiesewetter, F Jung, J Blume, et al.
Pageof 152